Astrazeneca Pharmaceuticals LP Awarded $286.9M Contract For 200 million Doses of AZD1222 Vaccine for COVID- 19.
AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, was awarded a $286,927,159 firm-fixed-price contract for the delivery of 200 million doses of AZD1222 vaccine for COVID- 19. Bids were solicited via the internet with one received. Work will be performed in West Chester Township, Ohio; and Albuquerque, New Mexico, with an estimated completion date of June 30, 2021. Fiscal 2021 other procurement (Army) funds in the amount of $286,927,159 were obligated at the time of the award. U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity (W15QKN-21-C-0003). (Awarded Oct. 28, 2020).
AstraZeneca Pharmaceuticals LP manufactures, fabricates, and processes drugs in pharmaceutical preparations. The Company focuses on several therapeutic areas such as cardiovascular and metabolic, gastrointestinal, neuroscience, oncology, respiratory, and infection. AstraZeneca Pharmaceuticals operates globally. (www.bloomberg.com)